Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre St... by Alessandro Parisi, Alessandro Parisi, Alessio Cortellini, Alessio Cortellini, Olga Venditti, Roberto Filippi, Roberto Filippi, Roberto Filippi, Lisa Salvatore, Lisa Salvatore, Giampaolo Tortora, Giampaolo Tortora, Michele Ghidini, Olga Nigro, Fabio Gelsomino, Ina Valeria Zurlo, Claudia Fulgenzi, Pasquale Lombardi, Susana Roselló Keränen, Susana Roselló Keränen, Ilaria Depetris, Riccardo Giampieri, Cristina Morelli, Pietro Di Marino, Pietro Di Marino, Francesca Romana Di Pietro, Nicoletta Zanaletti, Pasquale Vitale, Ingrid Garajova, Gian Paolo Spinelli, Federica Zoratto, Michela Roberto, Angelica Petrillo, Giacomo Aimar, Giacomo Aimar, Leonardo Patruno, Leonardo Patruno, Carla D’Orazio, Carla D’Orazio, Corrado Ficorella, Corrado Ficorella, Claudio Ferri, Giampiero Porzio, Giampiero Porzio

Get full text

Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell ca... by Loic Verlingue, Antoine Italiano, Hans Prenen, Eva Maria Guerra Alia, Diego Tosi, Ruth Perets, Iwona Lugowska, Vladimir Moiseyenko, Mahmut Gumus, Cagatay Arslan, Colin R. Lindsay, Sanjeev Deva, Álvaro Taus, Ana Oaknin, Sylvie Rottey, Irfan Cicin, Sema Sezgin Goksu, Alexey Smolin, Susana Roselló-Keränen, Christin Habigt, Daniel Marbach, Christophe Boetsch, David Dejardin, Nassim Sleiman, Stefan Evers, Muriel Richard, Caroline Ardeshir, Jehad Charo, Anton Kraxner, Volker Teichgräber, Nino Keshelava, Rafal Dziadziuszko

Get full text